Janssen Biotech
E242407
Janssen Biotech is a biopharmaceutical company known for developing and manufacturing innovative biologic therapies, including the blockbuster monoclonal antibody Remicade.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Janssen Biotech canonical | 8 |
| Centocor | 1 |
Statements (44)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
ⓘ
biotechnology company ⓘ subsidiary ⓘ |
| brandFamily |
Janssen Pharmaceuticals
ⓘ
surface form:
Janssen
|
| businessModel |
commercialization of biologic therapies
ⓘ
research and development of biologics ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| developed |
Remicade
ⓘ
Simponi ⓘ Stelara ⓘ |
| focus |
biologic drugs
ⓘ
monoclonal antibody therapies ⓘ |
| formerName |
Janssen Biotech
self-linksurface differs
ⓘ
surface form:
Centocor
|
| hasBlockbusterDrug | Remicade ⓘ |
| headquartersCountry |
United States of America
ⓘ
surface form:
United States
|
| headquartersLocation | Pennsylvania ⓘ |
| industry |
biopharmaceuticals
ⓘ
biotechnology ⓘ pharmaceuticals ⓘ |
| knownFor |
Remicade
ⓘ
developing biologic therapies ⓘ manufacturing biologic therapies ⓘ |
| notableDrug |
Remicade
ⓘ
Simponi ⓘ Stelara ⓘ |
| parentOrganization |
Janssen Pharmaceuticals
ⓘ
Johnson & Johnson ⓘ |
| partOf |
Janssen Pharmaceuticals
ⓘ
surface form:
Janssen Pharmaceutical Companies of Johnson & Johnson
|
| product |
Remicade
ⓘ
Simponi ⓘ Simponi ⓘ
surface form:
Simponi Aria
Stelara ⓘ |
| productType | monoclonal antibody ⓘ |
| regulatoryRegion | global ⓘ |
| specializesIn |
autoimmune diseases
ⓘ
immunology ⓘ inflammatory diseases ⓘ oncology ⓘ |
| subsidiaryOf | Johnson & Johnson ⓘ |
| therapeuticArea |
dermatology
ⓘ
gastroenterology ⓘ rheumatology ⓘ |
| therapyType |
biologic therapy
ⓘ
targeted immunotherapy ⓘ |
Referenced by (9)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Centocor